Mauritius vs Northern America: Proportion of the target population who received the final dose of
Mauritius
92.0%
in 2024
Northern America
55.0%
in 2024
Mauritius rank
6th
Northern America rank
9th
Proportion of the target population who received the final dose of over time
- Mauritius
- Northern America
How they compare
Mauritius currently reports 92.0% against 55.0% in Northern America, a difference of 37.0%.
That makes Mauritius's figure about 1.7 times Northern America's.
The two have swapped places 2 times across 8 shared years of data; in 2017 it was Mauritius ahead.
Mauritius ranks 6th and Northern America ranks 9th of 107 countries.
Mauritius has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mauritius | Northern America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.3% | 47.3% | 30.0% | Mauritius |
| 2020s | 54.2% | 53.8% | 0.4% | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Mauritius or Northern America?
- Mauritius, at 92.0% against 55.0% in Northern America as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Mauritius and Northern America?
- 37.0%, with Mauritius ahead.
- How many years of comparable data are there for Mauritius and Northern America?
- 8 years are reported by both, from 2017 to 2024.
- How do Mauritius and Northern America rank globally for proportion of the target population who received the final dose of?
- Mauritius ranks 6th and Northern America ranks 9th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.